Yuichiro Ueda

Yuichiro Ueda

Auto-generated profile, based on publicly available information

Yuichiro Ueda

Max Delbrück Center for Molecular Medicine Yuichiro Ueda Max Delbrück Center for Molecular Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2017 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Open access
PDF file
CKChee Keong Kwok
Chee Keong Kwok
YUYuichiro Ueda
Yuichiro Ueda
AKAsifiqbal Kadari
Asifiqbal Kadari
KGKatharina Günther
Katharina Günther
SESüleyman Ergün
Süleyman Ergün
FEFrank Edenhofer
Frank Edenhofer
The production of human induced pluripotent stem cells (hiPSCs) in quantities that are relevant for cell-based therapies and cell-loaded implants through standard adherent culture is hardly achievable and lacks process scalability. A promising approach to overcoming these hurdles is the culture of hiPSCs in suspension. In this study, stirred suspension culture vessels were investigated for their suitability in the expansion of two hiPSC lines inoculated as a single cell suspension, with a free scalability between volumes of 50 and 2400 ml. The simple and robust two-step process reported here first generates hiPSC aggregates of 324 ± 71 μm diameter in 7 days in 125 ml spinner flasks (100 ml volume). These are subsequently dissociated into a single cell suspension for inoculation in 3000 ml bioreactors (1000 ml volume), finally yielding hiPSC aggregates of 198 ± 58 μm after 7 additional days. In both spinner flasks and bioreactors, hiPSCs can be cultured as aggregates for more than 40 days in suspension, maintain an undifferentiated state as confirmed by the expression of pluripotency markers TRA-1-60, TRA-1-81, SSEA-4, OCT4, and SOX2, can differentiate into cells of all three germ layers, and can be directed to differentiate into specific lineages such as cardiomyocytes. Up to a 16-fold increase in hiPSC quantity at the 100 ml volume was achieved, corresponding to a fold increase per day of 2.28; at the 1000 ml scale, an additional 10-fold increase was achieved. Taken together, 16 × 106 hiPSCs were expanded into 2 × 109 hiPSCs in 14 days for a fold increase per day of 8.93. This quantity of hiPSCs readily meets the requirements of cell-based therapies and brings their clinical potential closer to fruition.

1 October 2018 in International Journal of Cardiology
Verified
Journal Article
Open access
NNNaoko Nose
Naoko Nose
RWRudolf A. Werner
Rudolf A. Werner
YUYuichiro Ueda
Yuichiro Ueda
KGKatharina Günther
Katharina Günther
CLConstantin Lapa
Constantin Lapa
THTakahiro Higuchi
Takahiro Higuchi
Recent developments in cellular reprogramming technology enable the production of virtually unlimited numbers of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM). Although hiPSC-CM share various characteristic hallmarks with endogenous cardiomyocytes, it remains a question as to what extent metabolic characteristics are equivalent to mature mammalian cardiomyocytes. Here we set out to functionally characterize the metabolic status of hiPSC-CM in vitro by employing a radionuclide tracer uptake assay. Cardiac differentiation of hiPSC was induced using a combination of well-orchestrated extrinsic stimuli such as WNT activation (by CHIR99021) and BMP signalling followed by WNT inhibition and lactate based cardiomyocyte enrichment. For characterization of metabolic substrates, dual tracer uptake studies were performed with 18F‑2‑fluoro‑2‑deoxy‑d‑glucose (18F-FDG) and 125I‑β‑methyl‑iodophenyl‑pentadecanoic acid (125I-BMIPP) as transport markers of glucose and fatty acids, respectively. After cardiac differentiation of hiPSCs, in vitro tracer uptake assays confirmed metabolic substrate shift from glucose to fatty acids that was comparable to those observed in native isolated human cardiomyocytes. Immunostaining further confirmed expression of fatty acid transport and binding proteins on hiPSC-CM. During in vitro cardiac maturation, we observed a metabolic shift to fatty acids, which are known as a main energy source of mammalian hearts, suggesting hi-PSC-CM as a potential functional phenotype to investigate alteration of cardiac metabolism in cardiac diseases. Results also highlight the use of available clinical nuclear medicine tracers as functional assays in stem cell research for improved generation of autologous differentiated cells for numerous biomedical applications.

6 October 2020 in Journal of Neural Transmission
Verified
Journal Article
Open access
PDF file
TITakashi I
Takashi I
YUYuichiro Ueda
Yuichiro Ueda
Philipp WörsdörferPhilipp Wörsdörfer
Philipp Wörsdörfer
YSYoshinori Sumita
Yoshinori Sumita
Izumi AsahinaIzumi Asahina
Izumi Asahina
Süleyman ErgünSüleyman Ergün
Süleyman Ergün
Salivary gland (SG) hypofunction is a common post-radiotherapy complication. Besides the parenchymal damage after irradiation (IR), there are also effects on mesenchymal stem cells (MSCs) which were shown to contribute to regeneration and repair of damaged tissues by differentiating into stromal cell types or releasing vesicles and soluble factors supporting the healing processes. However, there are no adequate reports about their roles during SG damage and regeneration so far. Using an irradiated SG mouse model, we performed certain immunostainings on tissue sections of submandibular glands at different time points after IR. Immunostaining for CD31 revealed that already one day after IR, vascular impairment was induced at the level of capillaries. In addition, the expression of CD44—a marker of acinar cells—diminished gradually after IR and, by 20 weeks, almost disappeared. In contrast, the number of CD34-positive cells significantly increased 4 weeks after IR and some of the CD34-positive cells were found to reside within the adventitia of arteries and veins. Laser confocal microscopic analyses revealed an accumulation of CD34-positive cells within the area of damaged capillaries where they were in close contact to the CD31-positive endothelial cells. At 4 weeks after IR, a fraction of the CD34-positive cells underwent differentiation into α-SMA-positive cells, which suggests that they may contribute to regeneration of smooth muscle cells and/or pericytes covering the small vessels from the outside. In conclusion, SG-resident CD34-positive cells represent a population of progenitors that could contribute to new vessel formation and/or remodeling of the pre-existing vessels after IR and thus, might be an important player during SG tissue healing.

6 March 2025
Verified
Preprint
Open access
PDF file
YUYuichiro Ueda
Yuichiro Ueda
CGCarolin Genehr
Carolin Genehr
This protocol outlines asmall molecules based, 2D differentiation methodfor generating high-purity human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Optimized for reproducibility across hiPSC lines, the procedure achieves robust cardiac differentiation through sequential modulation of Wnt signaling, yielding functional beating cardiomyocytes by days 7–10.

29 April 2026
Verified
Preprint
Open access
PDF file
YUYuichiro Ueda
Yuichiro Ueda
This protocol details an optimized workflow for the cryopreservation, thawing, and subsequent regrowth of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). It builds on the foundational approach using 10% DMSO / 90% KSR cryomedium with VIA Freeze controlled-rate freezing (adapted from Miller et al., 2020) and incorporates comprehensive evidence-based optimizations across all stages: cryomedium benchmarking against CryoStor CS10 and osmolyte-containing formulations (7.5% DMSO + 2.5% trehalose), advanced cooling profiles with controlled nucleation, pre-freeze ROCK inhibitor treatment, osmotic buffering during thaw, blebbistatin-mediated contraction inhibition post-thaw, optimized centrifugation, expanded replating medium options (including defined HSA-based medium), refined seeding density guidance (80,000-120,000 cells/cm²), ECM optimization, and functional recovery metrics (beating percentage, calcium transients, MEA/impedance readouts). The protocol is structured to support systematic Design of Experiments (DoE) for further optimization. All key steps include rationales and practical alternatives for head-to-head comparison.